Azenta Inc (AZTA)

Featured in Small-Cap Stocks

Azenta, Inc. is a NASDAQ-listed common stock issuer in the healthcare sector, focused on life sciences tools and services. The company provides solutions for the exploration and management of biological and chemical compound samples across markets in the United States, China, the United Kingdom, the rest of Europe, the Asia Pacific, and other international regions. Its operations are organized into two segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment includes automated storage systems, cryogenic equipment, automated sample tubes, consumables, instruments, controlled-rate thawing devices, repository services, and consulting support for experimental design and implementation. The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. Founded in 1978 and headquartered in Burlington, Massachusetts, the company adopted the Azenta name in December 2021 after previously operating as Brooks Automation, Inc. Azenta also maintains a strategic partnership with Frontier Space Ltd to support scientific experiments conducted in space.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-AZTA
$34.13
27.0% Upside
Undervalued
$27.80
3.4% Upside
Fair
Good
0.0%
August 11, 2026
-11.2x
0.8x
2.1x
1.21 B
739.6 M
4.4%
88.1%
4.3
-27.1%
Valuation • Fair Value

Azenta Inc (NASDAQ-AZTA) Fair Value by Valuation Model

Compare the primary fair value estimate for Azenta Inc (NASDAQ-AZTA) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$34.13

Estimated upside of 27.0% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$34.19

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$18.18

Earnings power value estimate.

Comps Fair Value

$36.72

Comparable-company valuation reference.

Analyst Price Target

$27.80

Analysts imply upside of 3.4%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Azenta Inc (NASDAQ-AZTA) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Azenta Inc (NASDAQ-AZTA)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

596.5 M

Current operating scale indicator.

Revenue Forecast

603.3 M

Forward revenue estimate.

EBITDA

36.716 M

Current operating profitability reference.

EBITDA Forecast

60.5 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Azenta Inc (NASDAQ-AZTA) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Azenta Inc (NASDAQ-AZTA)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-3.06

No elevated caution signal from this screen.

Altman Z-Score

4.3

Relatively strong balance-sheet zone.

FCF / Net Income

-27.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Azenta Inc (NASDAQ-AZTA). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Azenta Inc (NASDAQ-AZTA)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 11, 2026

Days to Earnings

21

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Azenta Inc (NASDAQ-AZTA), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Azenta Inc (NASDAQ-AZTA) Stock Forecast & Technical Outlook

Review Azenta Inc (NASDAQ-AZTA) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Azenta Inc (NASDAQ-AZTA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Azenta Inc (NASDAQ-AZTA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Azenta Inc (NASDAQ-AZTA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Azenta Inc (NASDAQ-AZTA) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Azenta Inc (NASDAQ-AZTA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Azenta Inc (NASDAQ-AZTA)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Azenta Inc (NASDAQ-AZTA) has a Hold consensus, with 2 buy, 3 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 3
Sell 0
FAQ Fast Investor Answers

Azenta Inc (NASDAQ-AZTA) Stock FAQ

Quick answers about Azenta Inc (NASDAQ-AZTA) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$34.13
Estimated upside 27.0%
Valuation Rating
Undervalued
Estimated upside of 27.0%
Analyst Target
$27.80
Implied upside 3.4%
Financial Health
Good
Current financial-health read

The current fair value estimate for Azenta Inc (NASDAQ-AZTA) is $34.13. This implies an estimated upside of 27.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 27.0% versus the current market price.

The available analyst price target for Azenta Inc (NASDAQ-AZTA) is $27.80. The analyst target implies estimated upside of 3.4%.

The current financial health read for Azenta Inc (NASDAQ-AZTA) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Azenta Inc (NASDAQ-AZTA) is August 11, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Azenta Inc (NASDAQ-AZTA) is -11.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Azenta Inc is 1.21 B.

The current enterprise value listed for Azenta Inc is 739.6 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Azenta Inc is NASDAQ-AZTA, and the stock is listed on NASDAQ.

Azenta Inc (NASDAQ-AZTA) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Azenta Inc is 4.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Azenta Inc is 88.1%. Free float helps investors understand how much of the share base is available for public trading.